TAP-independent MHC class I peptide antigen presentation to alloreactive CTL is enhanced by target cell incubation at subphysiologic temperatures

Journal of Immunology

Volumn 160, Issue 9, 1998, Pages 4305-4312

  Shi, Yan ^a,b,c   Smith, Kelly D ^a,b,d   Lutz, Charles T ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; BREFELDIN A; CD8 ANTIGEN; CHLOROQUINE; EPITOPE; HLA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE;

ALLOIMMUNITY; ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; GENE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; TARGET CELL; TEMPERATURE;

ANIMALS; ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-B7 ANTIGEN; HUMANS; MICE; PROTEIN CONFORMATION; TEMPERATURE;

EID: 0032080374     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. York, I. A., and K. L. Rock. 1996. Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14:369.
2. Ahn, K., A. Gruhler, B. Galocha, T. R. Jones, E. J. H. J. Wiertz, H. L. Ploegh, P. A. Peterson, Y. Yang, and K. Früh. 1997. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6:613.
3. Früh, K., K. Ahn, and P. A. Peterson. 1997. Inhibition of MHC class I antigen presentation by viral proteins. J. Mol. Med. 75:18.
4. Ljunggren, H.-G., N. J. Stam, C. Öhlén, J. J. Neefjes, P. Höglund, M.-T. Heemels, J. Bastin, T. N. M. Schumacher, A. Townsend, K. Kärre, and H. L. Ploegh. 1990. Empty MHC class I molecules come out in the cold. Nature 346:476.
5. Anderson, K. S., J. Alexander, M. Wei, and P. Cresswell. 1993. Intracellular transport of class I MHC molecules in antigen processing mutant cell lines. J. Immunol. 151:3407.
6. Schumacher, T. N. M., M.-T. Heemels, J. J. Neefjes, W. M. Kast, C. J. M. Melief, and H. L. Ploegh. 1990. Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. Cell 62:563.
7. Cerundolo, V., T. Elliott, J. Elvin, J. Bastin, H.-G. Rammensee, and A. Townsend. 1991. The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules. Eur. J. Immunol. 21:2069.
8. Ortiz-Navarrete, V., and G. J. Hämmerling. 1991. Surface appearance and instability of empty H-2 class I molecules under physiological conditions. Proc. Natl. Acad. Sci. USA 88:3594.
9. Esquivel, F., J. Yewdell, and J. Bennink. 1992. RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes. J. Exp. Med. 175:163.
10. Hosken, N. A., and M. J. Bevan. 1992. An endogenous antigenic peptide bypasses the class I antigen presentation defect in RMA-S. J. Exp. Med. 175:719.
11. d. Eur. J. Immunol. 23:1802.
12. Zhou, X., R. Glass, F. Momburg, G. J. Hämmerling, M. Jondal, and H.-G. Ljunggren. 1993. TAP2-defective RMA-S cells present Sendai virus antigen to cytotoxic T lymphocytes. Eur. J. Immunol. 23:1796.
13. Khanna, R., S. R. Burrows, D. J. Moss, and S. L. Silins. 1996. Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies. J. Virol. 70:5357.
14. De la Salle, H., E. Houssaint, M. A. Peyrat, D. Arnold, J. Salamero, D. Pinczon, S. Stevanovic, H. Bausinger, D. Fricker, E. Gomard, W. Biddison, P. Lehner, F. UytdeHaag, M. Sasportes, L. Donato, H. G. Rammensee, J. P. Cazenave, D. Hanau, M. M. Tongio, and M. Bonneville. 1997. Human peptide transporter deficiency: importance of HLA-B in the presentation of TAP-independent EBV antigens. J. Immunol. 158:4555.
15. Zweerink, H. J., M. C. Gammon, U. Utz, S. Y. Sauma, T. Harrer, J. C. Hawkins, R. P. Johnson, A. Sirotina, J. D. Hermes, B. D. Walker, and W. E. Biddison. 1993. Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells. J. Immunol. 150:1763.
16. Bacik, I., J. H. Cox, R. Anderson, J. W. Yewdell, and J. R. Bennink. 1994. TAP (transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino- but not carboxyl-terminus of the peptide. J. Immunol. 152:381.
17. Henderson, R. A., H. Michel, K. Sakaguchi, J. Shabanowitz, E. Appella, D. F. Hunt, and V. H. Engelhard. 1992. HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science 255:1264.
18. Wei, M. L., and P. Cresswell. 1992. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature 356:443.
19. Smith, K. D., and C. T. Lutz. 1996. Peptide-dependent expression of HLA-B7 on antigen processing deficient T2 cells. J. Immunol. 156:3755.
20. Sherman, L. A., and S. Chattopadhyay. 1993. The molecular basis of allorecognition. Annu. Rev. Immunol. 11:385.
21. + cytotoxic T lymphocytes in association with class I MHC protein. Cell 69:989.
22. Aldrich, C. J., A. DeCloux, A. S. Woods, R. J. Cotter, M. J. Soloski, and J. Forman. 1994. Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell 79:649.
23. + T cells can recognize unusual, rare, and unique processed peptide/MHC complexes. J. Immunol. 157:4464.
24. + cytotoxic T cell with apparent high affinity. J. Immunol 158:5797.
25. Öhlén, C., J. Bastin, H.-G. Ljunggren, L. Foster, E. Wolpert, G. Klein, A. R. M. Townsend, and K. M. Kärre. 1990. Resistance to H-2-restricted but not to allo-H2-specific graft and cytotoxic T lymphocyte responses in lymphoma mutant. J. Immunol. 145:52.
26. Smith, P. A., A. Brunmark, M. R. Jackson, and T. A. Potter. 1997. Peptide-independent recognition by alloreactive cytotoxic T lymphocytes (CTL). J. Exp. Med. 185:1023.
27. Smith, K. D., D. F. Epperson, and C. T. Lutz. 1995. Alloreactive cytotoxic T-lymphocyte-defined HLA-B7 subtypes differ in peptide antigen presentation. Immunogenetics 43:27.
28. + T cells recognize EBV antigen but poorly kill autologous EBV-infected B lymphoblasts: immunodominance is elicited by a peptide epitope that is presented at low levels in vitro. J. Immunol. 159:1844.
29. Smith, K. D., E. Huczko, V. H. Engelhard, Y.-Y. Li, and C. T. Lutz. 1997. Alloreactive cytotoxic T lymphocytes focus on specific major histocompatibility complex-bound peptides. Transplantation 64:351.
30. Smith, K. D., and C. T. Lutz. 1997. Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long α-helices. J. Immunol. 158:2805.
31. Kurago, Z. B., K. D. Smith, and C. T. Lutz. 1995. NK cell recognition of MHC class I: NK cells are sensitive to peptide-binding groove and surface α-nelical mutations that affect T cells. J. Immunol. 154:2631.
32. 3 domain of HLA-A molecules affects binding to CD8. Nature 338:345.
33. Parnes, J. R. 1989. Molecular biology and function of CD4 and CD8. Adv. Immunol. 44:265.
34. Al-Ramadi, B. K., M. T. Jelonek, L. F. Boyd, D. H. Margulies, and A. L. M. Bothwell. 1995. Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR. J. Immunol. 155:662.
35. Smith, K. D. B. E. Mace, A. Valenzuela, J. L. Vigna, J. A. McCutcheon, J. A. Barbosa, E. Huczko, V. H. Engelhard, and C. T. Lutz. 1996. Probing HLA-B7 conformational shifts induced by peptide-binding groove mutations and bound peptide with anti-HLA monoclonal antibodies. J. Immunol. 157:2470.
36. Berke, G. 1993. The functions and mechanisms of action of cytolytic lymphocytes. In Fundamental Immunology. W. E. Paul, ed. Raven Press, Ltd., New York, p. 629.
37. Yewdell, J. W., and J. R. Bennink. 1989. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes. Science 244:1072.
38. Huczko, E. L., W. M. Bodnar, D. Benjamin, K. Sakaguchi, N. Z. Zhu, J. Shabanowitz, R. A. Henderson, E. Appella, D. F. Hunt, and V. H. Engelhard. 1993. Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling. J. Immunol. 151:2572.
39. Mullbacher, A., A. B. Hill, R. V. Blanden, W. B. Cowden, N. J. C. King, and R. T. Hla. 1991. Alloreactive cytotoxic T cells recognize MHC class I antigen without peptide specificity. J. Immunol. 147:1765.
40. Bluestone, J. A., A. Kaliyaperumal, S. Jameson, S. Miller, and R. Dick II. 1993. Peptide-induced conformational changes in class I heavy chains alters allorecognition. J. Immunol. 151:3943.
41. Rötzschke, O., K. Falk, S. Faath, and H.-G. Rammensee. 1991. On the nature of peptides involved in T cell alloreactivity. J. Exp. Med. 174:1059.
42. Crumpacker, D. B., J. Alexander, P. Cresswell, and V. H. M. Engelhard. 1992. Role of endogenous peptides in murine allogeneic cytotoxic T cell responses assessed using transfectants of the antigen-processing mutant 174×CEM. T2. J. Immunol 148:3004.
43. Sherman, L. A., T. A. Burke, and J. A. Biggs. 1992. Extracellular processing of peptide antigens that bind class I major histocompatibility molecules. J. Exp. Med. 175:1221.
44. Pfeifer, J. D., M. J. Wick, R. L. Roberts, K. Findlay, S. J. Normark, and C. V. Harding. 1993. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361:359.
45. Liu, T., B. Chambers, A. D. Diehl, L. Van Kaer, M. Jondal, and H.-G. Ljunggren. 1997. TAP peptide transporter-independent presentation of heat-killed Sendai virus antigen on MHC class I molecules by splenic antigen-presenting cells. J. Immunol 159:5364.
46. Gabathuler, R., G. Reid, G. Kolaitis, J. Driscoll, and W. A. Jefferies. 1994. Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing. J. Exp. Med. 180:1415.
47. Hombach, J., H. Pircher, S. Tonegawa, and R. M. Zinkernagel. 1995. Strictly transporter of antigen presentation (TAP)-dependent presentation of an immunodominant cytotoxic T lymphocyte epitope in the signal sequence of a virus protein. J. Exp. Med. 182:1615.
48. Momburg, F., J. Roelse, G. J. Hämmerling, and J. J. Neefjes. 1994. Peptide size selection by the major histocompatibility complex-encoded peptide transporter. J. Exp. Med. 179:1613.
49. d alloreactive T cell hybridomas. Cell. Immunol. 164:81.
50. Sykulev, Y., M. Joo, I. Vturina, T. J. Tsomides, and H. N. Eisen. 1996. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 4:565.
51. Elliot, T. J., and H. N. Eisen. 1990. Cytotoxic T lymphocytes recognize a reconstituted class I histocompatibility antigen (HLA-A2) as an allogeneic target molecule. Proc. Natl. Acad. Sci. USA 87:5213.